Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03694522 |
|---|---|
| Brief Title: | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT) |
| First Submitted : | September 14, 2018 |
| First Submitted that Met QC Criteria : | October 1, 2018 |
| First Posted : | October 3, 2018 |
| Results First Submitted : | April 28, 2022 |
| Results First Submitted that Met QC Criteria : | April 28, 2022 |
| Results First Posted : | May 24, 2022 |
| Last Update Submitted that Met QC Criteria : | February 23, 2024 |
| Last Update Posted : | February 28, 2024 |